From the ‡Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.
§Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Mol Cell Proteomics. 2019 Jul;18(7):1468-1478. doi: 10.1074/mcp.TIR119.001385. Epub 2019 Apr 9.
Isobaric stable isotope labeling using, for example, tandem mass tags (TMTs) is increasingly being applied for large-scale proteomic studies. Experiments focusing on proteoform analysis in drug time course or perturbation studies or in large patient cohorts greatly benefit from the reproducible quantification of single peptides across samples. However, such studies often require labeling of hundreds of micrograms of peptides such that the cost for labeling reagents represents a major contribution to the overall cost of an experiment. Here, we describe and evaluate a robust and cost-effective protocol for TMT labeling that reduces the quantity of required labeling reagent by a factor of eight and achieves complete labeling. Under- and overlabeling of peptides derived from complex digests of tissues and cell lines were systematically evaluated using peptide quantities of between 12.5 and 800 μg and TMT-to-peptide ratios (wt/wt) ranging from 8:1 to 1:2 at different TMT and peptide concentrations. When reaction volumes were reduced to maintain TMT and peptide concentrations of at least 10 mm and 2 g/l, respectively, TMT-to-peptide ratios as low as 1:1 (wt/wt) resulted in labeling efficiencies of > 99% and excellent intra- and interlaboratory reproducibility. The utility of the optimized protocol was further demonstrated in a deep-scale proteome and phosphoproteome analysis of patient-derived xenograft tumor tissue benchmarked against the labeling procedure recommended by the TMT vendor. Finally, we discuss the impact of labeling reaction parameters for N-hydroxysuccinimide ester-based chemistry and provide guidance on adopting efficient labeling protocols for different peptide quantities.
等重同位素标记(如串联质谱标签,TMT)在大规模蛋白质组学研究中得到了越来越多的应用。在药物时间过程或干扰研究或在大型患者队列中,专注于蛋白质形式分析的实验极大地受益于单个肽在样品之间的可重复定量。然而,此类研究通常需要标记数百微克的肽,以至于标记试剂的成本是实验总成本的主要贡献者。在这里,我们描述并评估了一种强大且经济有效的 TMT 标记方案,该方案将所需标记试剂的量减少了 8 倍,并实现了完全标记。通过在 12.5 至 800 μg 的肽量和 TMT 与肽的比率(wt/wt)范围为 8:1 至 1:2 的情况下,从组织和细胞系的复杂消化物中衍生的肽的低标记和过标记进行了系统评估。当反应体积减少以保持 TMT 和肽的浓度分别至少为 10 mM 和 2 g/l 时,TMT 与肽的比率低至 1:1(wt/wt),标记效率>99%,并且具有出色的实验室间和实验室内重现性。该优化方案的实用性在与 TMT 供应商推荐的标记程序进行基准比较的情况下,在患者来源的异种移植肿瘤组织的深度蛋白质组学和磷酸蛋白质组学分析中得到了进一步证明。最后,我们讨论了基于 N-羟基琥珀酰亚胺酯化学的标记反应参数的影响,并就采用不同肽量的有效标记方案提供了指导。